Speakers:
Cheng Liguo, Assistant Director of Programming, Jiangsu Hengrui Medicine Co., Ltd.
Huang Xiao,Clinical R&D Programmer at Jiangsu Hengrui Medicine Co., Ltd.
Speech topic : Using JMP Clinical to implement medical monitoring of tumor clinical trials during the COVID-19 pandemic
Abstract:
In 2020, Covid-19 became a global pandemic, and the progress of clinical trials will also be affected. In this speech, the speaker will demonstrate how to use JMP Clinical to implement medical monitoring of tumor clinical trials during the COVID-19 pandemic from multiple aspects through simulated cases. This includes risk-based monitoring and enrollment regularity monitoring, the impact of the pandemic on the distribution of protocol deviations, the type and number of days of delayed medication due to the pandemic, tumor response and progression-free survival analysis, etc., and generate corresponding subject lists and subject resumes to facilitate medical review of data and timely response.
In this speech, the speaker will demonstrate how to use JMP Clinical to implement medical monitoring of tumor clinical trials during the COVID-19 pandemic through simulated cases from multiple aspects, including risk-based monitoring and enrollment regularity monitoring, the impact of the pandemic on the distribution of protocol deviations, the type and number of days of delayed medication due to the pandemic, tumor response and progression-free survival analysis, etc., and generate corresponding subject lists and subject resumes to facilitate medical review of data and timely response.
